Evidence map›Paper›PMID 28501348›Full record

ReviewTrends in molecular medicine2017

Single-Cell RNA Sequencing: Unraveling the Brain One Cell at a Time.

Dimitry Ofengeim, Nikolaos Giagtzoglou, Dann Huh, Chengyu Zou, Junying Yuan

Abstract readReview
In one paragraph

Review in Trends in molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dimitry OfengeimBiogen, Neurology, 115 Broadway Street, Cambridge, MA 02142, USA. Electronic address: dimitry.ofengeim@biogen.com.
Nikolaos GiagtzoglouBiogen, Neurology, 115 Broadway Street, Cambridge, MA 02142, USA.
Dann HuhBiogen, Neurology, 115 Broadway Street, Cambridge, MA 02142, USA.
Chengyu ZouDepartment of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA.
Junying YuanDepartment of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA. Electronic address: jyuan@hms.harvard.edu.

Funding

Investigating the neuroinflammatory role of RIP1 kinaseR01AG047231 · NIA · HARVARD MEDICAL SCHOOL · PI YUAN, JUNYING · 2014 to 2018
$2.2M
Investigating the mechanism of TNFalpha mediated cell death in oligodendrocytesR01NS082257 · NINDS · HARVARD MEDICAL SCHOOL · PI YUAN, JUNYING · 2013 to 2017
$1.9M
NIA NIH HHS R01 AG047231NINDS NIH HHS R01 NS082257
6 · The paper itself

Abstract

Single-cell RNA sequencing (scRNA-seq) is an exciting new technology allowing the analysis of transcriptomes from individual cells, and is ideally suited to address the inherent complexity and dynamics of the central nervous system. scRNA-seq has already been applied to the study of molecular taxonomy of the brain. These works have paved the way to expanding our understanding of the nervous system and provide insights into cellular susceptibilities and molecular mechanisms in neurological and neurodegenerative diseases. We discuss recent progress and challenges in applying this technology to advance our understanding of the brain. We advocate the application of scRNA-seq in the discovery of targets and biomarkers as a new approach in developing novel therapeutics for the treatment of neurodegenerative diseases.

Indexed as

AnimalsBiomarkersHigh-Throughput Nucleotide SequencingHumansNeurodegenerative DiseasesSequence Analysis, RNABiomarkers

Identifiers

PMID28501348
PMCPMC5531055

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.